ANIK
ANIK
NASDAQ · Biotechnology

Anika Therapeutics Inc

$13.81
-0.14 (-1.00%)
As of Nov 14, 2:22 AM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +73.6% upside
Low Target $18.55
Average Target $23.98
High Target $27.85
Current Price $13.81
Current
$13.81
Target
$23.98
$18.55 $23.98 avg $27.85
Scenario Analysis
Bear Case
$18.55
34.3%
Low target
Base Case
$23.98
+73.6%
Avg target
Bull Case
$27.85
+101.7%
High target
Risk/Reward
3.0x
Favorable
Price in Context
52-Week High
$22.88
-39.6% from high
52-Week Low
$9.01
+53.3% from low
Target vs 52W High
$23.98
+4.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.7%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.6%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -92.0%
MRNA
Moderna Inc
Hold 31 32% $149.45 -33.1%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.2%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -33.8%